Enterotoxigenicity of mature 45-kilodalton and processed 35-kilodalton forms of hemagglutinin protease purified from a cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain.

Infection and Immunity
A GhoshA Pal

Abstract

Cholera toxin gene-negative Vibrio cholerae non-O1, non-O139 strain PL-21 is the etiologic agent of cholera-like syndrome. Hemagglutinin protease (HAP) is one of the major secretory proteins of PL-21. The mature 45-kDa and processed 35-kDa forms of HAP were purified in the presence and absence of EDTA from culture supernatants of PL-21. Enterotoxigenicities of both forms of HAP were tested in rabbit ileal loop (RIL), Ussing chamber, and tissue culture assays. The 35-kDa HAP showed hemorrhagic fluid response in a dose-dependent manner in the RIL assay. Histopathological examination of 20 microg of purified protease-treated rabbit ileum showed the presence of erythrocytes and neutrophils in the upper part of the villous lamina propria. Treatment with 40 microg of protease resulted in gross damage of the villous epithelium with inflammation, hemorrhage, and necrosis. The 35-kDa form of HAP, when added to the lumenal surface of rat ileum loaded in an Ussing chamber, showed a decrease in the intestinal short-circuit current and a cell rounding effect on HeLa cells. The mature 45-kDa form of HAP showed an increase in intestinal short-circuit current in an Ussing chamber and a cell distending effect on HeLa cells. These results show t...Continue Reading

References

Aug 1, 1978·The Journal of Infectious Diseases·D R Schneider, C D Parker
Jan 1, 1976·Methods in Enzymology·J M Prescott, S H Wilkes
Nov 1, 1990·Infection and Immunity·K K BanerjeeA C Ghose
Jul 1, 1986·The Journal of Infectious Diseases·B A Booth, R A Finkelstein
May 1, 1971·The American Journal of Physiology·M FieldI McColl
Mar 1, 1982·Infection and Immunity·D M LyerlyT D Wilkins
Nov 1, 1996·Infection and Immunity·C Toma, Y Honma
Aug 26, 1998·Infection and Immunity·H H Kimsey, M K Waldor
Mar 5, 2002·Clinical and Diagnostic Laboratory Immunology·Firdausi QadriAnn-Mari Svennerholm
Jan 29, 2003·Proceedings of the National Academy of Sciences of the United States of America·Qing XuJohn J Mekalanos
May 9, 2003·Pediatric Research·Lei LuW Allan Walker
Oct 1, 1953·The Journal of Pathology and Bacteriology·S N DE, D N CHATTERJE
Dec 23, 2003·Infection and Immunity·Xin ZhouJames B Kaper
Feb 10, 2004·Proceedings of the National Academy of Sciences of the United States of America·Shah M FaruqueJohn J Mekalanos
Apr 23, 2005·Infection and Immunity·Luis GarcíaRafael Fando

❮ Previous
Next ❯

Citations

Sep 4, 2009·Microbial Ecology·Darrell Jay GrimesTracy Berutti
Dec 27, 2008·Bulletin of Experimental Biology and Medicine·E A BardakchianR V Pisanov
Jul 18, 2012·Bulletin of Experimental Biology and Medicine·S R SayamovE A Bardakhchian
May 24, 2012·Applied Biochemistry and Biotechnology·Sree Renjini IsacDurg Vijai Singh
Jul 3, 2013·Antimicrobial Agents and Chemotherapy·Pallashri SahaKeya Chaudhuri
Dec 15, 2010·Infection and Immunity·Simon HoustonCaroline E Cameron
Apr 7, 2011·Biocontrol Science·Sumio Shinoda, Shin-Ichi Miyoshi
Mar 10, 2016·Toxicon : Official Journal of the International Society on Toxinology·Jorge A Benitez, Anisia J Silva
May 16, 2008·The FEBS Journal·Karolis VaitkeviciusSun N Wai
Aug 23, 2012·PLoS Pathogens·Simon HoustonCaroline E Cameron
Sep 15, 2020·FEMS Microbiology Reviews·Nikola ZlatkovSun Nyunt Wai
Apr 9, 2021·Journal of Medical Microbiology·Sharda Prasad AwasthiShinji Yamasaki
Aug 6, 2021·Annual Review of Microbiology·Mariana G SartorioM Florencia Haurat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.